| Financial Year |
March 31 2023 |
| Monetary Funds |
325,147,610.66 |
| Held-for-trading Financial Assets |
574,400,499.18 |
| Notes Receivable |
1,626,690.81 |
| Accounts Receivable |
298,130,849.73 |
| Advances to Suppliers |
-- |
| Other Receivables |
5,436,795.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
911,770.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
71,237,158.09 |
| Total Current Assets |
1,296,019,971.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,814,614.05 |
| Investment Properties |
32,190,425.30 |
| Fixed Assetes |
6,090,045.69 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,908,621.38 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
335,338.82 |
| Deferred Income Tax Assets |
20,963,249.47 |
| Other Non-Current Assets |
199,488,395.09 |
| Sub-Total of Non-Current Assets |
312,441,310.80 |
| Total Assets |
1,608,461,282.29 |
| Short-Term Loans |
120,335,550.81 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
13,785,543.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,385,396.64 |
| Taxes Payable |
10,150,820.08 |
| Interest Payable |
-- |
| Dividend Payable |
120,385.89 |
| Other payables |
24,330,779.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,976,110.29 |
| Other Current Liabilities |
397,559.11 |
| Sub-Total of Current Liabilities |
210,985,673.93 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,205,627.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,728,107.28 |
| Total Liabilities |
215,713,781.21 |
| Paid-In Capital(Or Share Stock) |
102,209,704.00 |
| Capital Surplus |
968,316,562.99 |
| Surplus Reserve |
30,050,380.65 |
| LESS:Treasury Stock |
20,455,569.74 |
| Undistributed Profits |
312,135,955.66 |
| Minority Stockholder's Interest |
490,467.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,392,257,033.56 |
| Owner's Equity（Stockholder's Equity） |
1,392,747,501.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,608,461,282.29 |
